Home > Insider Trading > Filing (0001144204-15-055254)

Filing Details

Accession Number:: 0001144204-15-055254
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-09-16 16:16:22
Reporting Period:: 2015-09-14

Filing Date:: 2015-09-16
Accepted Time:: 2015-09-16 16:16:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369868	China Biologic Products Inc.	CBPO	Biological Products, (No Disgnostic Substances) (2836)	752308816

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1555364	Ming Yang	18Th Floor, Jialong International Building, 19 Chaoyang Park Road Beijing F4 100125	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-09-14	1,000	$9.85	36,086	No	4	M	Direct
Common Stock	Disposition	2015-09-14	11,304	$97.08	24,782	No	4	S	Direct
Common Stock	Acquisiton	2015-09-15	9,000	$9.85	33,782	No	4	M	Direct
Common Stock	Disposition	2015-09-15	9,000	$94.56	24,782	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-09-14	1,000	$0.00	1,000	$9.85
Common Stock	Stock Option (right to buy)	Disposition	2015-09-15	9,000	$0.00	9,000	$9.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
49,000	2013-09-01	2022-08-31	No	4	M	Direct
40,000	2013-09-01	2022-08-31	No	4	M	Direct

Footnotes

Represents 1,000 shares of common stock acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 6 below for further details on the relevant stock options.
Represents 11,304 shares of common stock (the "September 14 Sold Common Stock") sold on the open market at a weighted average price of $97.08 per share on September 14, 2015. The September 14 Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase 1,000 shares of the Issuer's common stock and vesting of 10,304 restricted stocks.
Represents 9,000 shares of common stock (the "September 15 Sold Common Stock") sold on the open market at a weighted average price of $94.56 per share on September 15, 2015. The September 15 Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase 9,000 shares of the Issuer's common stock. See Footnote 7 below for further details on the relevant stock options.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $93.70 to $100.50, inclusive. The Reporting Person undertakes to provide to any security holders of China Biologic Products, Inc. (the "Issuer") or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 4 and Footnote 5 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $94.00 to $95.54, inclusive.
Represents previously reported stock options to purchase 1,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were scheduled to vest in four equal portions on a quarterly basis over a four-year period, with the initial vesting date being September 1, 2013, provided that the Reporting Person is employed by the Issuer on each vesting date.
Represents previously reported stock options to purchase 9,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were scheduled to vest in four equal portions on a quarterly basis over a four-year period, with the initial vesting date being September 1, 2013, provided that the Reporting Person is employed by the Issuer on each vesting date.
Includes the balance of the previously reported stock options to purchase 50,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012.